Xie HG - Search Results

1

Hypertension in black people: study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on race.

Stein CM, Lang CC, Xie HG, Wood AJ. Stein CM, et al. Among authors: xie hg. Pharmacogenetics. 2001 Mar;11(2):95-110. doi: 10.1097/00008571-200103000-00001. Pharmacogenetics. 2001. PMID: 11266083 Review.

2

Genetic polymorphism of (S)-mephenytoin 4'-hydroxylation in populations of African descent.

Xie HG, Kim RB, Stein CM, Wilkinson GR, Wood AJ. Xie HG, et al. Br J Clin Pharmacol. 1999 Sep;48(3):402-8. doi: 10.1046/j.1365-2125.1999.00009.x. Br J Clin Pharmacol. 1999. PMID: 10510153 Free PMC article.

3

Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world.

Xie HG, Stein CM, Kim RB, Wilkinson GR, Flockhart DA, Wood AJ. Xie HG, et al. Pharmacogenetics. 1999 Oct;9(5):539-49. Pharmacogenetics. 1999. PMID: 10591534

4

Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension.

Xie HG, Kim RB, Stein CM, Gainer JV, Brown NJ, Wood AJ. Xie HG, et al. Pharmacogenetics. 1999 Oct;9(5):651-6. Pharmacogenetics. 1999. PMID: 10591546

5

Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals.

Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH, Gainer JV, Brown NJ, Haines JL, Wood AJ. Xie HG, et al. Pharmacogenetics. 1999 Aug;9(4):511-6. Pharmacogenetics. 1999. PMID: 10780271

6

Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.

Xie HG, Stein CM, Kim RB, Gainer JV, Sofowora G, Dishy V, Brown NJ, Goree RE, Haines JL, Wood AJ. Xie HG, et al. Clin Pharmacol Ther. 2000 Jun;67(6):670-5. doi: 10.1067/mcp.2000.106293. Clin Pharmacol Ther. 2000. PMID: 10872649

7

Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo.

Xie HG, Dishy V, Sofowora G, Kim RB, Landau R, Smiley RM, Zhou HH, Wood AJ, Harris P, Stein CM. Xie HG, et al. Pharmacogenetics. 2001 Apr;11(3):191-7. doi: 10.1097/00008571-200104000-00002. Pharmacogenetics. 2001. PMID: 11337934

8

In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism.

Sofowora G, Dishy V, Xie HG, Imamura H, Nishimi Y, Morales CR, Morrow JD, Kim RB, Stein CM, Wood AJ. Sofowora G, et al. Among authors: xie hg. Pharmacogenetics. 2001 Dec;11(9):809-14. doi: 10.1097/00008571-200112000-00009. Pharmacogenetics. 2001. PMID: 11740345

9

Molecular basis of ethnic differences in drug disposition and response.

Xie HG, Kim RB, Wood AJ, Stein CM. Xie HG, et al. Annu Rev Pharmacol Toxicol. 2001;41:815-50. doi: 10.1146/annurev.pharmtox.41.1.815. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264478 Review.

10

The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.

Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ. Dishy V, et al. Among authors: xie hg. N Engl J Med. 2001 Oct 4;345(14):1030-5. doi: 10.1056/NEJMoa010819. N Engl J Med. 2001. PMID: 11586955 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters